Retatrutide
Triple-receptor research compound. GLP-1 / GIP / glucagon pathway investigation.
RESTRICTED ACCESS
All products on this site are research chemicals sold strictly for laboratory and analytical purposes. Not for human or animal consumption. Confirm the following to enter.
I do not agree, exitMETABOLIC & GLP-1
Triple-agonist research peptide. GLP-1, GIP, and glucagon receptor engagement.
ABOUT THIS COMPOUND
Retatrutide is a synthetic triple-agonist research peptide that engages the GLP-1, GIP, and glucagon receptors. As a novel multi-receptor research compound, it sits at the leading edge of metabolic-pathway investigation.
Researchers use Retatrutide to study triple-pathway pharmacology, comparing the dynamics of single-receptor and multi-receptor agonism in metabolic-axis research. In our facility it is solid-phase synthesized from domestically sourced amino acids and HPLC-verified above 99% purity per lot.
SPECIFICATIONS
RESEARCH APPLICATIONS
All applications are investigative. This compound is sold for research-use only and is not for human or animal consumption.
QUALITY ASSURANCE
A current-lot Certificate of Analysis is available for every compound. Email us with the product and lot number; we'll send the documentation. Read about our lab testing →
YOU MAY ALSO RESEARCH
QUESTIONS?
Lot questions, COA requests, institutional accounts, reach the team directly.
CONTACT US